Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2013

Dec 4, 2013

30198_dirs_2013-12-04_a7a255e2-2f43-403f-95c8-efa779f50d0f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2013-12-02

Reporting Person: SAYER KEVIN R (Director, President & COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-12-02 Common Stock D 8701.0 $32.8714 Disposed 338662 Direct

Footnotes

F1: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.

F2: Included in this number are 229,064 unvested restricted stock units, 150,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016, 62,500 of which were granted on March 8, 2012 and shall vest through March 8, 2015, and 16,564 of which were granted on June 1, 2011 and shall vest through June 1, 2014.